Level of hormones in menopause in relation to diabetic retinopathy among type 2 diabetic women
- 26 March 2021
- journal article
- research article
- Published by Taylor & Francis in Health Care for Women International
- Vol. 42 (1) , 58-66
Abstract
Hormonal transition among middle-aged women with type 2 diabetes may exert an impact in the development of diabetic retinopathy (DR). In this cross-sectional study, we aimed to assess the levels of estradiol, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) in the presence of DR and their relationship with risk factors for DR among pre- and post-menopausal women with type 2 diabetes. Serum levels of estradiol, FSH, and LH were measured using the immunoassay technique. All statistical analysis was performed using SPSS software. From the 255 participants, diabetes duration-matched, 35 premenopausal, and 57 postmenopausal women were selected for analysis. The levels of estradiol, LH, and FSH were found to be similar in participants with and without DR among pre- and post-menopausal women with diabetes. Estradiol level was not found to be related with the risk factors of DR among women with type 2 diabetes. In conclusion, female sex hormone, estradiol is not related to the presence of DR. Further prospective studies are necessary to reveal the mechanistic role of this hormone in the development of DR.Keywords
This publication has 17 references indexed in Scilit:
- Diabetic Retinopathy and Sex HormonesIOSR Journal of Dental and Medical Sciences, 2017
- 2. Classification and Diagnosis of DiabetesDiabetes Care, 2014
- Estrogen prevents high-glucose-induced damage of retinal ganglion cells via mitochondrial pathwayGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: A clinic-based retrospective longitudinal studyDiabetes Research and Clinical Practice, 2014
- Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndromeMenopause, 2008
- Estrogens and the diabetic kidneyGender Medicine, 2008
- Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional studyClimacteric, 2005
- Ocular Blood Flow Velocity Determined by Color Doppler Imaging in Diabetic RetinopathyOphthalmologica, 2004
- Estrogen Protects the Inner Retina from Apoptosis and Ischemia-Induced Loss of Vesl-1L/Homer 1c Immunoreactive Synaptic ConnectionsInvestigative Ophthalmology & Visual Science, 2003
- Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.Diabetes Care, 1999